| [1] |
高燕, 黄国英. 先天性心脏病病因及流行病学研究进展[J]. 中国循证儿科杂志, 2008, 3(3): 213-222.
|
| [2] |
Zhou S, Wang J, Wang Q, et al. Essential role of the ELABELA-APJ signaling pathway in cardiovascular system development and diseases[J]. J Cardiovasc Pharmacol, 2020, 75(4): 284-291.
doi: 10.1097/FJC.0000000000000803
pmid: 32000202
|
| [3] |
孟卓, 周双, 洪楠超. 小分子激素Elabela在心血管发育中的作用研究进展[J]. 中华儿科杂志, 2018, 56(12): 954-957.
|
| [4] |
Wang Z, Huang J. Apela promotes cardiomyocyte differentiation from transgenic human embryonic stem cell lines[J]. Appl Biochem Biotechnol, 2019, 189(2): 396-410.
doi: 10.1007/s12010-019-03012-2
pmid: 31025171
|
| [5] |
Xu J, Chen L, Jiang Z, et al. Biological functions of Elabela, a novel endogenous ligand of APJ receptor[J]. J Cell Physiol, 2018, 233(9): 6472-6482.
doi: 10.1002/jcp.26492
pmid: 29350399
|
| [6] |
陈海英, 高连如, 张宁坤. Apelin/APJ与胚胎心肌分化[J]. 现代生物医学进展, 2012, 12(9): 1766-1768.
|
| [7] |
蔡科, 桂永浩, 王凤. Tbx2基因调控胚胎心脏发育的研究进展[J]. 国际儿科学杂志, 2018, 45(8): 575-578.
|
| [8] |
Eberlein J, Herdt L, Malchow J, et al. Molecular and cellular mechanisms of vascular development in zebrafish[J]. Life (Basel), 2021, 11(10): 1088.
|
| [9] |
O’Dowd BF, Heiber M, chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11[J]. Gene, 1993, 136(1-2): 355-360.
doi: 10.1016/0378-1119(93)90495-o
pmid: 8294032
|
| [10] |
Zhang Y, Wang Y, Lou Y, et al. Elabela, a newly discovered APJ ligand: similarities and differences with Apelin[J]. Peptides, 2018, 109: 23-32.
doi: S0196-9781(18)30175-X
pmid: 30267732
|
| [11] |
Kuba K, Sato T, Imai Y, et al. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology[J]. Peptides, 2019, 111: 62-70.
doi: S0196-9781(18)30085-8
pmid: 29684595
|
| [12] |
Liu W, Yan J, Pan W, et al. Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system[J]. Ann Transl Med, 2020, 8(5): 243.
doi: 10.21037/atm.2020.02.07
pmid: 32309390
|
| [13] |
Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun, 1998, 251(2): 471-476.
doi: 10.1006/bbrc.1998.9489
|
| [14] |
Yang P, Read C, Kuc RE, et al. Elabela/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension[J]. Circulation, 2017, 135(12): 1160-1173.
doi: 10.1161/CIRCULATIONAHA.116.023218
pmid: 28137936
|
| [15] |
Chng SC, Ho L, Tian J, et al. ELABELA: a hormone essential for heart development signals via the apelin receptor[J]. Dev Cell, 2013, 27(6): 672-680.
doi: 10.1016/j.devcel.2013.11.002
pmid: 24316148
|
| [16] |
章清, 瞿红鹰, 黄永顺, 等. Apelin/APJ系统在器官纤维化中研究进展[J]. 中国职业医学, 2020, 47(6): 722-727.
|
| [17] |
田艳君, 姜云璐, 韩爱忠, 等. Apelin/APJ系统及其基因多态性与心脑血管疾病的相关性[J]. 生理科学进展, 2019, 50(6): 423-428.
|
| [18] |
D’Aniello C, Lonardo E, Iaconis S, et al. G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway[J]. Circ Res, 2009, 105(3): 231-238.
doi: 10.1161/CIRCRESAHA.109.201186
pmid: 19574549
|
| [19] |
Ho L, Tan SY, Wee S, et al. ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K/AKT pathway[J]. Cell Stem Cell, 2015, 17(4): 435-447.
doi: 10.1016/j.stem.2015.08.010
pmid: 26387754
|
| [20] |
Eberlé D, Marousez L, Hanssens S, et al. Elabela and Apelin actions in healthy and pathological pregnancies[J]. Cytokine Growth Factor Rev, 2019, 46: 45-53.
doi: 10.1016/j.cytogfr.2019.03.003
|
| [21] |
Lu L, Cao J, Li L, et al. Elabela, a new endogenous ligand of APJ, functions in embryos and adults organisms[J]. Acta Biochim Biophys Sin (Shanghai), 2017, 49(4): 378-381.
doi: 10.1093/abbs/gmx014
|
| [22] |
Helker CS, Schuermann A, Pollmann C, et al. The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis[J]. Elife, 2015, 4: e06726.
doi: 10.7554/eLife.06726
|
| [23] |
Singh AM, Reynolds D, Cliff T, et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation[J]. Cell Stem Cell, 2012, 10(3): 312-326.
doi: 10.1016/j.stem.2012.01.014
pmid: 22385658
|
| [24] |
Norris ML, Pauli A, Gagnon JA, et al. Toddler signaling regulates mesodermal cell migration downstream of Nodal signaling[J]. Elife, 2017, 6: e22626.
doi: 10.7554/eLife.22626
|
| [25] |
Wu L, Chen L, Li L. Apelin/APJ system: a novel promising therapy target for pathological angiogenesis[J]. Clin Chim Acta, 2017, 466: 78-84.
doi: S0009-8981(16)30527-7
pmid: 28025030
|
| [26] |
Cox CM, D'Agostino SL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo[J]. Dev Biol, 2006, 296(1): 177-189.
doi: 10.1016/j.ydbio.2006.04.452
pmid: 16750822
|
| [27] |
Kidoya H, Ueno M, Yamada Y, et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis[J]. EMBO J, 2008, 27(3): 522-534.
doi: 10.1038/sj.emboj.7601982
pmid: 18200044
|
| [28] |
Scott IC, Masri B, D'Amico LA, et al. The G protein-coupled receptor Agtrl1b regulates early development of myocardial progenitors[J]. Dev Cell, 2007, 12(3): 403-413.
doi: 10.1016/j.devcel.2007.01.012
pmid: 17336906
|
| [29] |
Zeng XX, Wilm TP, Sepich DS, et al. Apelin and its receptor control heart field formation during zebrafish gastrulation[J]. Dev Cell, 2007, 12(3): 391-402.
doi: 10.1016/j.devcel.2007.01.011
|
| [30] |
Huang Z, He L, Chen Z, et al. Targeting drugs to APJ receptor: from signaling to pathophysiological effects[J]. J Cell Physiol, 2018, 234(1): 61-74.
doi: 10.1002/jcp.27047
pmid: 30070701
|
| [31] |
马秀娟, 郝晓莹. 影响胚胎血管形成的因子的研究进展[J]. 中国生育健康杂志, 2020, 31(6): 583-585.
|
| [32] |
Freyer L, Hsu CW, Nowotschin S, et al. Loss of Apela peptide in mice causes low penetrance embryonic lethality and defects in early mesodermal derivatives[J]. Cell Rep, 2017, 20(9): 2116-2130.
doi: S2211-1247(17)31106-3
pmid: 28854362
|
| [33] |
Ho L, van Dijk M, Chye STJ, et al. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice[J]. Science, 2017, 357(6352): 707-713.
doi: 10.1126/science.aam6607
pmid: 28663440
|
| [34] |
Marsault E, Llorens-Cortes C, Iturrioz X, et al. The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders[J]. Ann N Y Acad Sci, 2019, 1455(1): 12-33.
doi: 10.1111/nyas.v1455.1
|
